We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Receives Tentative Approval for Generic Sonata
Teva Receives Tentative Approval for Generic Sonata
December 13, 2005
The FDA has granted tentative approval to Teva Pharmaceutical’s abbreviated new drug application (ANDA) for zaleplon capsules in 5- and 10-mg dosage strengths.
